EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

The status of late-onset vacuous chewing/perioral movements during long-term neuroleptic treatment in rodents: tardive dyskinesia or dystonia?



The status of late-onset vacuous chewing/perioral movements during long-term neuroleptic treatment in rodents: tardive dyskinesia or dystonia?



Psychopharmacology 91(1): 136-137




(PDF emailed within 0-6 h: $19.90)

Accession: 041760024

Download citation: RISBibTeXText

PMID: 2881317

DOI: 10.1007/bf00690944



Related references

The rat model of tardive dyskinesia: Relationship between vacuous chewing movements and gross motor activity during acute and long-term haloperidol treatment. Life Sciences 57(24): 2263-2272, 1995

Neuroleptic-induced vacuous chewing movements as an animal model of tardive dyskinesia: a study in three rat strains. Psychopharmacology 102(4): 474-478, 1990

Neuroleptic-induced vacuous chewing movements in rodents: Incidence and effects of long-term increases in haloperidol dose. Psychopharmacology 117(1): 74-81, 1995

Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia. Psychopharmacology 101(4): 431-447, 1990

Glycine and D-cycloserine attenuate vacuous chewing movements in a rat model of tardive dyskinesia. Brain Research 1004(1-2): 142-147, 2004

The opioid antagonist naloxone suppresses vacuous chewing movements in a rodent model of tardive dyskinesia. Society for Neuroscience Abstracts 25(1-2): 1122, 1999

The mitochondrial toxin 3-nitropropionic acid induced vacuous chewing movements in rats. Implications for tardive dyskinesia?. Psychopharmacology 119(4): 474-476, 1995

Lipoic acid and haloperidol-induced vacuous chewing movements: Implications for prophylactic antioxidant use in tardive dyskinesia. Progress in Neuro-Psychopharmacology & Biological Psychiatry 72(): 23-29, 2016

Intrastriatal dopamine D3 receptor antisense attenuates vacuous chewing movements in a rodent model of tardive dyskinesia. Society for Neuroscience Abstracts 26(1-2): Abstract No -533 5, 2000

Extract of Ginkgo biloba is equivalent to vitamin E in attenuating and preventing vacuous chewing movements in a rat model of tardive dyskinesia. Behavioural Pharmacology 24(7): 610-616, 2016

Pro-Leu-glycinamide and its peptidomimetic, PAOPA, attenuate haloperidol induced vacuous chewing movements in rat: A model of human tardive dyskinesia. Peptides (New York) 24(2): 313-319, February, 2003